Clinical Trial Update: 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension [Phase 4]

View source ↗

Summary

Phase 4 randomized, open-label trial evaluating the effect of food on the efficacy and safety of aliskiren 300 mg in patients with hypertension; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-01-01